Welcome to The Conference
The conference will address applications of genome editing in a variety of biological systems, featuring:
- A high-impact, packed day of talks, discussions and several hours of networking
- Oral presentations on latest developments in the field of genome editing by an international faculty of leading researchers from academia and industry
- Update on CRISPR patents
- Posters
- Trade exhibition
- Excellent networking opportunities, and a relaxed and friendly environment
We welcome proposals for oral and poster presentation on new applications and experimental design of genome editing and gene modulation technologies to large-scale screening, pathway elucidation, disease modelling, therapy and relevant emerging technologies. We particularly encourage final year doctoral students and early/mid career postdoctoral researchers/junior group leaders to submit oral abstracts, as we believe this event will provide their research an excellent exposure, critical analysis by attending senior researchers and new career opportunities. If you are interested in presenting your research at this meeting please submit your abstract for pre-approval at CRISPR@LPMHealthcare.com. Please use this Abstract Template if you are submitting an abstract.
The conference will be hosted along with our 7th annual Aptamers 2020 and 6th annual Oligo 2020 Oxford (separate registration required).
Confirmed Speakers
Dr Mark Behlke, Chief Scientist, Integrated DNA Technologies, USA
Dr Ultan McDermott, Chief Scientist, Oncology, AstraZeneca Oncology R&D, CRUK Cambridge Institute, Cambridge, UK
Professor Stephen Hart, Professor in Molecular Genetics & Deputy Head of Department, Genetics and Genomic Medicine Department, UCL Great Ormond Street Institute of Child Health, London, UK
Professor Andrew Sewell, Systems Immunity Research Institute, Cardiff University, Cardiff, United Kingdom
Professor Jim Hughes, Professor of Gene Regulation, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK
Dr Lydia Teboul, Head of Molecular and Cellular Biology , The Mary Lyon Centre, MRC Harwell Institute, Harwell, UK
Dr Katharina Boroviak, Group Leader, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, Hinxton, UK
Professor Yaohe Wang, Professor of Cancer Cell and Gene Therapy, Barts Cancer Institute, Queen Mary University of London, London, UK
Dr Lisa Mohamet, Group Leader Functional Genomics, GlaxoSmithKline, Manchester, UK
Dr Daniel Ebner, Principal Investigator, Target Discovery Institute, Head of Scientific Operation, National Phenotypic Screening Centre – Oxford, Nuffield Department of Medicine, University of Oxford, Oxford, UK
Dr Dominic Owens, De Bruijn Lab, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK
Dr Philip Webber, Dehns Attorneys Oxford, UK
More speakers to be announced soon…
